This episode continues our discussion on the new bivalent COVID boosters that target the original virus and also Omicron subvariants BA.4 and BA.5.
Azra Behlim, PharmD, MBA
Associate Vice President, Pharmacy Sourcing and Program Services
Tomas Villanueva, DO, MBA, FACPE, SFHM
Senior Principal, Clinical Operations and Quality
[00:30] Is the booster safe?
[01:32] How long to wait after previous vaccine
[02:47] Whether or not to get flu vaccines
[05:58] Feasibility of using the booster as an initial vaccine in a series
[09:05] Nasal vaccines and mucosal immunity
Links | Resources:
To contact Modern Practice: firstname.lastname@example.org
FDA announcement on new vaccine boosters (8-31-22): Click here